The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
OPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer.
The global OPDIVO market was valued at US$ 9567 million in 2023 and is anticipated to reach US$ 15620 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The OPDIVO market is primarily driven by the growing demand for innovative immunotherapy treatments in the field of oncology. OPDIVO (nivolumab) is a checkpoint inhibitor that harnesses the immune system to fight cancer cells by blocking certain proteins that suppress the immune response. The increasing prevalence of cancer cases, coupled with the need for targeted therapies that offer improved survival rates and fewer adverse effects compared to traditional treatments, contributes to market growth. Moreover, the expanding range of approved indications for OPDIVO, including advanced melanoma, lung cancer, and other malignancies, further propels adoption. However, challenges include managing potential immune-related adverse events and addressing variations in patient responses to immunotherapy. Navigating the competitive landscape in the immunotherapy market and ensuring affordability and access to these treatments for a broader patient population pose ongoing concerns. The market's success hinges on continuous research to identify optimal treatment combinations and patient profiles for OPDIVO, comprehensive patient education about potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and research institutions to optimize cancer treatment while addressing the evolving challenges associated with OPDIVO therapy.
This report aims to provide a comprehensive presentation of the global market for OPDIVO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OPDIVO.
Report Scope
The OPDIVO market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OPDIVO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OPDIVO manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Ono Pharmaceutical
Segment by Type
10ml
4ml
24ml
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OPDIVO manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OPDIVO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
OPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer.
The global OPDIVO market was valued at US$ 9567 million in 2023 and is anticipated to reach US$ 15620 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The OPDIVO market is primarily driven by the growing demand for innovative immunotherapy treatments in the field of oncology. OPDIVO (nivolumab) is a checkpoint inhibitor that harnesses the immune system to fight cancer cells by blocking certain proteins that suppress the immune response. The increasing prevalence of cancer cases, coupled with the need for targeted therapies that offer improved survival rates and fewer adverse effects compared to traditional treatments, contributes to market growth. Moreover, the expanding range of approved indications for OPDIVO, including advanced melanoma, lung cancer, and other malignancies, further propels adoption. However, challenges include managing potential immune-related adverse events and addressing variations in patient responses to immunotherapy. Navigating the competitive landscape in the immunotherapy market and ensuring affordability and access to these treatments for a broader patient population pose ongoing concerns. The market's success hinges on continuous research to identify optimal treatment combinations and patient profiles for OPDIVO, comprehensive patient education about potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and research institutions to optimize cancer treatment while addressing the evolving challenges associated with OPDIVO therapy.
This report aims to provide a comprehensive presentation of the global market for OPDIVO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OPDIVO.
Report Scope
The OPDIVO market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OPDIVO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OPDIVO manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Ono Pharmaceutical
Segment by Type
10ml
4ml
24ml
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OPDIVO manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OPDIVO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 OPDIVO Market Overview
1.1 Product Overview and Scope of OPDIVO
1.2 OPDIVO Segment by Type
1.2.1 Global OPDIVO Market Value Comparison by Type (2024-2030)
1.2.2 10ml
1.2.3 4ml
1.2.4 24ml
1.3 OPDIVO Segment by Application
1.3.1 Global OPDIVO Market Value by Application: (2024-2030)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global OPDIVO Market Size Estimates and Forecasts
1.4.1 Global OPDIVO Revenue 2019-2030
1.4.2 Global OPDIVO Sales 2019-2030
1.4.3 Global OPDIVO Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 OPDIVO Market Competition by Manufacturers
2.1 Global OPDIVO Sales Market Share by Manufacturers (2019-2024)
2.2 Global OPDIVO Revenue Market Share by Manufacturers (2019-2024)
2.3 Global OPDIVO Average Price by Manufacturers (2019-2024)
2.4 Global OPDIVO Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OPDIVO, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OPDIVO, Product Type & Application
2.7 OPDIVO Market Competitive Situation and Trends
2.7.1 OPDIVO Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest OPDIVO Players Market Share by Revenue
2.7.3 Global OPDIVO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OPDIVO Retrospective Market Scenario by Region
3.1 Global OPDIVO Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global OPDIVO Global OPDIVO Sales by Region: 2019-2030
3.2.1 Global OPDIVO Sales by Region: 2019-2024
3.2.2 Global OPDIVO Sales by Region: 2025-2030
3.3 Global OPDIVO Global OPDIVO Revenue by Region: 2019-2030
3.3.1 Global OPDIVO Revenue by Region: 2019-2024
3.3.2 Global OPDIVO Revenue by Region: 2025-2030
3.4 North America OPDIVO Market Facts & Figures by Country
3.4.1 North America OPDIVO Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America OPDIVO Sales by Country (2019-2030)
3.4.3 North America OPDIVO Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe OPDIVO Market Facts & Figures by Country
3.5.1 Europe OPDIVO Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe OPDIVO Sales by Country (2019-2030)
3.5.3 Europe OPDIVO Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OPDIVO Market Facts & Figures by Country
3.6.1 Asia Pacific OPDIVO Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific OPDIVO Sales by Country (2019-2030)
3.6.3 Asia Pacific OPDIVO Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America OPDIVO Market Facts & Figures by Country
3.7.1 Latin America OPDIVO Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America OPDIVO Sales by Country (2019-2030)
3.7.3 Latin America OPDIVO Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OPDIVO Market Facts & Figures by Country
3.8.1 Middle East and Africa OPDIVO Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa OPDIVO Sales by Country (2019-2030)
3.8.3 Middle East and Africa OPDIVO Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OPDIVO Sales by Type (2019-2030)
4.1.1 Global OPDIVO Sales by Type (2019-2024)
4.1.2 Global OPDIVO Sales by Type (2025-2030)
4.1.3 Global OPDIVO Sales Market Share by Type (2019-2030)
4.2 Global OPDIVO Revenue by Type (2019-2030)
4.2.1 Global OPDIVO Revenue by Type (2019-2024)
4.2.2 Global OPDIVO Revenue by Type (2025-2030)
4.2.3 Global OPDIVO Revenue Market Share by Type (2019-2030)
4.3 Global OPDIVO Price by Type (2019-2030)
5 Segment by Application
5.1 Global OPDIVO Sales by Application (2019-2030)
5.1.1 Global OPDIVO Sales by Application (2019-2024)
5.1.2 Global OPDIVO Sales by Application (2025-2030)
5.1.3 Global OPDIVO Sales Market Share by Application (2019-2030)
5.2 Global OPDIVO Revenue by Application (2019-2030)
5.2.1 Global OPDIVO Revenue by Application (2019-2024)
5.2.2 Global OPDIVO Revenue by Application (2025-2030)
5.2.3 Global OPDIVO Revenue Market Share by Application (2019-2030)
5.3 Global OPDIVO Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb OPDIVO Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Myers Squibb OPDIVO Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Ono Pharmaceutical
6.2.1 Ono Pharmaceutical Corporation Information
6.2.2 Ono Pharmaceutical Description and Business Overview
6.2.3 Ono Pharmaceutical OPDIVO Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ono Pharmaceutical OPDIVO Product Portfolio
6.2.5 Ono Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OPDIVO Industry Chain Analysis
7.2 OPDIVO Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OPDIVO Production Mode & Process
7.4 OPDIVO Sales and Marketing
7.4.1 OPDIVO Sales Channels
7.4.2 OPDIVO Distributors
7.5 OPDIVO Customers
8 OPDIVO Market Dynamics
8.1 OPDIVO Industry Trends
8.2 OPDIVO Market Drivers
8.3 OPDIVO Market Challenges
8.4 OPDIVO Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global OPDIVO Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global OPDIVO Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global OPDIVO Market Competitive Situation by Manufacturers in 2023
Table 4. Global OPDIVO Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global OPDIVO Sales Market Share by Manufacturers (2019-2024)
Table 6. Global OPDIVO Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global OPDIVO Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market OPDIVO Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of OPDIVO, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of OPDIVO, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of OPDIVO, Product Type & Application
Table 12. Global Key Manufacturers of OPDIVO, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OPDIVO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OPDIVO as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OPDIVO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global OPDIVO Sales by Region (2019-2024) & (K Units)
Table 18. Global OPDIVO Sales Market Share by Region (2019-2024)
Table 19. Global OPDIVO Sales by Region (2025-2030) & (K Units)
Table 20. Global OPDIVO Sales Market Share by Region (2025-2030)
Table 21. Global OPDIVO Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global OPDIVO Revenue Market Share by Region (2019-2024)
Table 23. Global OPDIVO Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global OPDIVO Revenue Market Share by Region (2025-2030)
Table 25. North America OPDIVO Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America OPDIVO Sales by Country (2019-2024) & (K Units)
Table 27. North America OPDIVO Sales by Country (2025-2030) & (K Units)
Table 28. North America OPDIVO Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America OPDIVO Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe OPDIVO Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe OPDIVO Sales by Country (2019-2024) & (K Units)
Table 32. Europe OPDIVO Sales by Country (2025-2030) & (K Units)
Table 33. Europe OPDIVO Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe OPDIVO Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific OPDIVO Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific OPDIVO Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific OPDIVO Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific OPDIVO Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific OPDIVO Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America OPDIVO Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America OPDIVO Sales by Country (2019-2024) & (K Units)
Table 42. Latin America OPDIVO Sales by Country (2025-2030) & (K Units)
Table 43. Latin America OPDIVO Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America OPDIVO Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa OPDIVO Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa OPDIVO Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa OPDIVO Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa OPDIVO Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa OPDIVO Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global OPDIVO Sales (K Units) by Type (2019-2024)
Table 51. Global OPDIVO Sales (K Units) by Type (2025-2030)
Table 52. Global OPDIVO Sales Market Share by Type (2019-2024)
Table 53. Global OPDIVO Sales Market Share by Type (2025-2030)
Table 54. Global OPDIVO Revenue (US$ Million) by Type (2019-2024)
Table 55. Global OPDIVO Revenue (US$ Million) by Type (2025-2030)
Table 56. Global OPDIVO Revenue Market Share by Type (2019-2024)
Table 57. Global OPDIVO Revenue Market Share by Type (2025-2030)
Table 58. Global OPDIVO Price (US$/Unit) by Type (2019-2024)
Table 59. Global OPDIVO Price (US$/Unit) by Type (2025-2030)
Table 60. Global OPDIVO Sales (K Units) by Application (2019-2024)
Table 61. Global OPDIVO Sales (K Units) by Application (2025-2030)
Table 62. Global OPDIVO Sales Market Share by Application (2019-2024)
Table 63. Global OPDIVO Sales Market Share by Application (2025-2030)
Table 64. Global OPDIVO Revenue (US$ Million) by Application (2019-2024)
Table 65. Global OPDIVO Revenue (US$ Million) by Application (2025-2030)
Table 66. Global OPDIVO Revenue Market Share by Application (2019-2024)
Table 67. Global OPDIVO Revenue Market Share by Application (2025-2030)
Table 68. Global OPDIVO Price (US$/Unit) by Application (2019-2024)
Table 69. Global OPDIVO Price (US$/Unit) by Application (2025-2030)
Table 70. Bristol-Myers Squibb Corporation Information
Table 71. Bristol-Myers Squibb Description and Business Overview
Table 72. Bristol-Myers Squibb OPDIVO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bristol-Myers Squibb OPDIVO Product
Table 74. Bristol-Myers Squibb Recent Developments/Updates
Table 75. Ono Pharmaceutical Corporation Information
Table 76. Ono Pharmaceutical Description and Business Overview
Table 77. Ono Pharmaceutical OPDIVO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Ono Pharmaceutical OPDIVO Product
Table 79. Ono Pharmaceutical Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. OPDIVO Distributors List
Table 83. OPDIVO Customers List
Table 84. OPDIVO Market Trends
Table 85. OPDIVO Market Drivers
Table 86. OPDIVO Market Challenges
Table 87. OPDIVO Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of OPDIVO
Figure 2. Global OPDIVO Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global OPDIVO Market Share by Type in 2023 & 2030
Figure 4. 10ml Product Picture
Figure 5. 4ml Product Picture
Figure 6. 24ml Product Picture
Figure 7. Global OPDIVO Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global OPDIVO Market Share by Application in 2023 & 2030
Figure 9. Retail Pharmacy
Figure 10. Hospital Pharmacy
Figure 11. Other
Figure 12. Global OPDIVO Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global OPDIVO Market Size (2019-2030) & (US$ Million)
Figure 14. Global OPDIVO Sales (2019-2030) & (K Units)
Figure 15. Global OPDIVO Average Price (US$/Unit) & (2019-2030)
Figure 16. OPDIVO Report Years Considered
Figure 17. OPDIVO Sales Share by Manufacturers in 2023
Figure 18. Global OPDIVO Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest OPDIVO Players: Market Share by Revenue in 2023
Figure 20. OPDIVO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global OPDIVO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America OPDIVO Sales Market Share by Country (2019-2030)
Figure 23. North America OPDIVO Revenue Market Share by Country (2019-2030)
Figure 24. United States OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe OPDIVO Sales Market Share by Country (2019-2030)
Figure 27. Europe OPDIVO Revenue Market Share by Country (2019-2030)
Figure 28. Germany OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific OPDIVO Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific OPDIVO Revenue Market Share by Region (2019-2030)
Figure 35. China OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America OPDIVO Sales Market Share by Country (2019-2030)
Figure 45. Latin America OPDIVO Revenue Market Share by Country (2019-2030)
Figure 46. Mexico OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa OPDIVO Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa OPDIVO Revenue Market Share by Country (2019-2030)
Figure 51. Turkey OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE OPDIVO Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of OPDIVO by Type (2019-2030)
Figure 55. Global Revenue Market Share of OPDIVO by Type (2019-2030)
Figure 56. Global OPDIVO Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of OPDIVO by Application (2019-2030)
Figure 58. Global Revenue Market Share of OPDIVO by Application (2019-2030)
Figure 59. Global OPDIVO Price (US$/Unit) by Application (2019-2030)
Figure 60. OPDIVO Value Chain
Figure 61. OPDIVO Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
